Hepatoma Research
All Journals
Search Log In
Home Articles Special Topics Volumes Webinars Videos
Hepatoma Research
Search Submit
Home Articles Special Topics Volumes Webinars Videos

Volume

First cases of MPV17 related mitochondrial DNA depletion syndrome with compound heterozygous mutations in p.R50Q/p.R50W: a case report

Interim results from ongoing Phase III placebo-controlled, randomized trial of hepcortespenlisimut-L for advanced hepatocellular carcinoma indication

Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment

Frailty and Liver resection: where do we stand?

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer

Coffee protection against the development of hepatocellular carcinoma: review article

Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases

The interplay between direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C

Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series

Microwave ablation of hepatocellular carcinomas in octogenarians

Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals

Prehabilitation in elderly patients scheduled for liver resection and protocol for Recovery Of Surgery in Elderly

Ion channels in liver diseases and hepatocellular carcinoma: potential tools for diagnosis, prognosis, and therapy

Cytotoxic immune cell-based immunotherapy for hepatocellular carcinoma

Treatment efficacy for patients with chronic hepatitis C and preexisting hepatocellular carcinoma by directly acting antivirals

Direct acting antivirals therapy and hepatocellular carcinoma risk in patients with hepatitis C virus

Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective

Diagnosing non-hepatocellular carcinoma malignancies on CT/MRI and contrast enhanced ultrasound: the Liver Imaging Reporting and Data System approach

Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related hepatocellular carcinoma

The advancement of immunotherapy in hepatocellular carcinoma

Recent advances regarding tumor microenvironment and immunotherapy in hepatocellular carcinoma

The impact of direct-acting antivirals on hepatitis C associated hepatocellular carcinoma

Direct-acting antivirals and risk of hepatocellular carcinoma: from genetic signature to metabolic risk factors

Hepatocellular carcinoma and hepatitis C virus infection in Latin America: epidemiology, diagnosis and treatment

Treatment options for recurrence of hepatocellular carcinoma after surgical resection: review of the literature and current recommendations for management

Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma

Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients?

Epidemiology of hepatocellular carcinoma in metabolic liver disease

Imaging biomarkers for predicting poor prognosis of hepatocellular carcinoma: a review

Role of laparoscopic and robotic liver resection compared to open surgery in elderly hepatocellular carcinoma patients: a systematic review and meta-analysis

Intraarterial and intravenous contrast enhanced CT and MR imaging of multi-step hepatocarcinogenesis defining the early stage of hepatocellular carcinoma development

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma

Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly

Predictive factors for hepatocellular carcinoma recurrence after curative treatments

Impact of direct-acting antivirals on <i>de novo</i> occurrence of hepatocellular carcinoma in hepatitis C virus patients

Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction

Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis

Conventional type 1 dendritic cells in protective antitumor immunity and its potential in hepatocellular carcinoma

Stereotactic body radiation therapy for the management of HCC

The advances in immunotherapy for hepatocellular carcinoma

β-catenin in intranuclear inclusions of hepatocellular carcinoma

Comprehending the therapeutic effects of stereotactic body radiation therapy for small hepatocellular carcinomas based on imagings

Imaging assessment after SBRT for hepatocellular carcinoma

For dietary advice in end-stage liver cirrhosis resting metabolic rate should be measured, not estimated

Contrast-enhanced ultrasonography with Sonazoid in hepatocellular carcinoma diagnosis

Pathomolecular characterization of HCC in non-cirrhotic livers

Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy

Combined transarterial chemoembolization and stereotactic body radiation therapy as a bridge therapy to liver transplant for hepatocellular carcinoma

Risk factors for hepatocellular carcinoma recurrence after liver transplantation

Liver imaging reporting and data system and CT/MRI diagnosis of hepatocellular carcinoma

Global pattern and trend of liver cancer survival: a systematic review of population-based studies

Contrast-enhanced ultrasound liver reporting and data system for hepatocellular carcinoma diagnosis

Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation recipients with hepatocellular carcinoma - a single center retrospective study

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response

Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI

Detection of circulating tumor cells in hepatocellular carcinoma: applications in diagnosis, prognosis prediction and personalized treatment

Comparison and analysis of the efficacy of drug therapy for liver cancer

Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma

Viral hepatitis as a risk factor for the development of hepatocellular carcinoma

Contrast-enhanced ultrasound of focal liver masses

Can radiotherapy finally “go live” in the management of liver metastases?

CT and MRI of the liver for hepatocellular carcinoma

Robotic-assisted laparoscopic liver resection in hepatocellular carcinoma

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a change of terminology?

Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus

Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review

Systemic therapy for advanced cholangiocarcinoma: new options on the horizon

Post liver transplant recurrence in patients with hepatocellular carcinoma: not necessarily the end of the road!

The transcontinental variability of nonalcoholic fatty liver disease

Stereotactic body radiation therapy for primary liver tumors with adverse factors

Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma

Prevalence and incidence of intra- and extrahepatic complications of NAFLD in patients with type 2 diabetes mellitus

p53 functional loss, stemness and hepatocellular carcinoma

Current status of laparoscopic repeat liver resection for hepatocellular carcinoma

Current status of laparoscopic repeat liver resection for recurrent hepatocellular carcinoma

Advances in minimally invasive surgery for hepatocellular carcinoma

Living donor liver transplantation for patients with advanced hepatocellular carcinoma

Should selection criteria for HCC be the same (or different) between LDLT and DDLT?

The role of genetic factors in HBV-related HCC: perspectives from local genetic backgrounds and clinical epidemiology

Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological findings and pathobiological mechanisms

Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?

Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential

Genetic risk factors associated with NAFLD

Actions for 0 selected articles

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties